These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16638370)

  • 1. Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis.
    Lawrence A; Khanna D; Misra R; Aggarwal A
    Dermatol Online J; 2006 Jan; 12(1):2. PubMed ID: 16638370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
    Matsushita T; Hasegawa M; Hamaguchi Y; Takehara K; Sato S
    J Rheumatol; 2006 Feb; 33(2):275-84. PubMed ID: 16465658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of endothelin-1 and its binding sites in scleroderma skin.
    Vancheeswaran R; Azam A; Black C; Dashwood MR
    J Rheumatol; 1994 Jul; 21(7):1268-76. PubMed ID: 7525957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis.
    Yanaba K; Muroi E; Yoshizaki A; Hara T; Ogawa F; Shimizu K; Yozaki M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Sep; 36(9):1917-23. PubMed ID: 19605674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.
    Kissin EY; Merkel PA; Lafyatis R
    Arthritis Rheum; 2006 Nov; 54(11):3655-60. PubMed ID: 17075814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-G expression in the skin of patients with systemic sclerosis.
    Wastowski IJ; Sampaio-Barros PD; Amstalden EM; Palomino GM; Marques-Neto JF; Crispim JC; Biral AC; Rassi DM; Carosella ED; Moreau P; Donadi EA
    J Rheumatol; 2009 Jun; 36(6):1230-4. PubMed ID: 19369464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis.
    Martin P; Teodoro WR; Velosa AP; de Morais J; Carrasco S; Christmann RB; Goldenstein-Schainberg C; Parra ER; Katayama ML; Sotto MN; Capelozzi VL; Yoshinari NH
    Autoimmun Rev; 2012 Sep; 11(11):827-35. PubMed ID: 22406224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.
    Davies CA; Jeziorska M; Freemont AJ; Herrick AL
    Hum Pathol; 2006 Feb; 37(2):190-7. PubMed ID: 16426919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular damage and lack of angiogenesis in systemic sclerosis skin.
    Konttinen YT; Mackiewicz Z; Ruuttila P; Ceponis A; Sukura A; Povilenaite D; Hukkanen M; Virtanen I
    Clin Rheumatol; 2003 Sep; 22(3):196-202. PubMed ID: 14505210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum interleukin 23 in patients with systemic sclerosis.
    Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
    J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of 2'5'oligoadenylate synthetase and double-stranded RNA dependent protein kinase messenger RNAs on affected skin of systemic sclerosis patients.
    Coelho LF; de Oliveira JG; de Oliveira DB; Guedes AC; Lanna CC; Prados RZ; Ferreira PC; Bonjardim CA; Kroon EG
    Arch Dermatol Res; 2007 Aug; 299(5-6):259-62. PubMed ID: 17541615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis.
    Davies CA; Herrick AL; Cordingley L; Freemont AJ; Jeziorska M
    Rheumatology (Oxford); 2009 Aug; 48(8):876-82. PubMed ID: 19542215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement.
    Del Rosso A; Distler O; Milia AF; Emanueli C; Ibba-Manneschi L; Guiducci S; Conforti ML; Generini S; Pignone A; Gay S; Madeddu P; Matucci-Cerinic M
    Ann Rheum Dis; 2005 Mar; 64(3):382-7. PubMed ID: 15708892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudoscleroderma associated with cancer.
    Kikuchi K; Hoashi T; Yazawa N; Tamaki K
    Clin Exp Dermatol; 2006 May; 31(3):381-3. PubMed ID: 16681582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous cytokine gene expression by cultured skin fibroblasts of systemic sclerosis. Correlation with collagen synthesis.
    Zurita-Salinas CS; Richaud-Patin Y; Krötzsch-Gómez E; Llorente L; Alcocer-Varela J; Díaz-de-León L; Palacios-Boix A
    Rev Invest Clin; 1998; 50(2):97-104. PubMed ID: 9658927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.
    Furst DE; Clements PJ; Steen VD; Medsger TA; Masi AT; D'Angelo WA; Lachenbruch PA; Grau RG; Seibold JR
    J Rheumatol; 1998 Jan; 25(1):84-8. PubMed ID: 9458208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of activated complement complex C5b-9 and complement receptor C5a in skin biopsies of patients with systemic sclerosis (scleroderma).
    Sprott H; Müller-Ladner U; Distler O; Gay RE; Barnum SR; Landthaler M; Schölmerich J; Lang B; Gay S
    J Rheumatol; 2000 Feb; 27(2):402-4. PubMed ID: 10685805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis.
    Davies CA; Jeziorska M; Freemont AJ; Herrick AL
    Rheumatology (Oxford); 2006 Nov; 45(11):1349-55. PubMed ID: 17050587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.